ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae (NCT02180945) | Clinical Trial Compass
CompletedNot Applicable
ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae
France110 participantsStarted 2013-07
Plain-language summary
The objective of this study is to evaluate the safety and performance post last embolization with Onyx
Who can participate
Age range18 Years – 99 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The patient has an intracranial dAVF which could be treated by ONYX embolization, whether or not associated to other embolization products.
* The patient is at least 18 years of age.
Exclusion Criteria:
* The patient needs to be treated for the dAVF with another treatment option (for example by surgery) than embolization within a period of less than 6 months (to be counted as from the first treatment)
* The patient participates to another clinical study during the treatment period for his/her dAVF, evaluating another medical devices, procedure or medication.
* The patient refuses to give consent to the collection and processing of data required for centralized monitoring.
* A condition which could jeopardize follow-up of the patient.